These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 301055

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomas.
    Lum HE, Miller M, Davol PA, Grabert RC, Davis JB, Lum LG.
    Anticancer Res; 2005; 25(1A):43-52. PubMed ID: 15816517
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ, Sieg SM, Beckett ML, Schellhammer PF, Ladaga LE, Wright GL.
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Specificity of cell membrane antigens in prostate cancer.
    Brannen GE, Coffey DS.
    Natl Cancer Inst Monogr; 1978 Dec; (49):251-3. PubMed ID: 86164
    [Abstract] [Full Text] [Related]

  • 27. Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes.
    Savage PA, Vosseller K, Kang C, Larimore K, Riedel E, Wojnoonski K, Jungbluth AA, Allison JP.
    Science; 2008 Jan 11; 319(5860):215-20. PubMed ID: 18187659
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Serial circulating immune complex levels and mitogen responses during progressive tumor growth in WF rats.
    Rodrick ML, Steele G, Ross DS, Lahey SJ, Deasy JM, Rayner AA, Harte PJ, Wilson RE, Munroe AE, King VP.
    J Natl Cancer Inst; 1983 Jun 11; 70(6):1113-8. PubMed ID: 6602239
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prostate specific antigen inhibits immune responses in vitro: a potential role in prostate cancer.
    Kennedy-Smith AG, McKenzie JL, Owen MC, Davidson PJ, Vuckovic S, Hart DN.
    J Urol; 2002 Aug 11; 168(2):741-7. PubMed ID: 12131362
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ.
    Cancer Res; 2001 Mar 01; 61(5):2239-49. PubMed ID: 11280793
    [Abstract] [Full Text] [Related]

  • 39. In vitro induction of lymphoblasts and cytotoxic lymphocytes with prostate tumor cells.
    Frost P, Rose NR.
    Natl Cancer Inst Monogr; 1978 Dec 01; (49):169-72. PubMed ID: 571044
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.